Comment on: Yohshino et al.: combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6). Cancer Chemother Pharmacol (2017) 80:1239-1247
1 Department of Gynecology and Gynecologic Oncology, HELIOS Dr. Horst-Schmidt-Kliniken Wiesbaden, Ludwig-Erhard-Str. 100, 65199, Wiesbaden, Germany. [email protected].
2 Department of Obstetrics and Gynecology, Klinikum Darmstadt, Darmstadt, Germany.